A carvedilol to bisoprolol interchange program was carried out in a Singapore hospital with substantial cost savings of US$116 per patient-year without increase in adverse outcomes.
Doreen S. Tan, PharmD, BPharm, BCPS (AQ Cardiology)
Advertisement
Articles by Doreen S. Tan, PharmD, BPharm, BCPS (AQ Cardiology)
Advertisement
Latest Updated Articles
- Therapeutic Interchange of Carvedilol to Bisoprolol for Chronic Heart Failure: The Singapore Experience
Published: June 10th 2012 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Therapeutic Cancer Vaccines: Are We There Yet?
2
Emerging Biomarkers Open New Frontiers in Lung Cancer Therapy
3
Transforming HER2+ Metastatic Breast Cancer Treatment With Targeted ADC Therapy
4
Weekly Paclitaxel May Hold the Key to Pembrolizumab’s Success in Platinum-Resistance Ovarian Cancer
5
